Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Plasma Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Large-scale testing (Phase 3)Study completedNCT03652064
What this trial is testing

A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 395
Large-scale testing (Phase 3)Study completedNCT00025909
What this trial is testing

Intermittent vs. Continuous HAART to Treat Chronic HIV Infection

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 90
Early research (Phase 1)UnknownNCT00004036
What this trial is testing

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemia+5 more
The Cleveland Clinic 30
Testing effectiveness (Phase 2)Study completedNCT00378209
What this trial is testing

Bortezomib, Lenalidomide, and Dexamethasone Combination Therapy for Patients With Relapsed or Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Dana-Farber Cancer Institute 65
Large-scale testing (Phase 3)Looking for participantsNCT07623798
What this trial is testing

A Study in Participants With Relapsed or Refractory Multiple Myeloma for IBI3003

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Innovent Biologics (Suzhou) Co. Ltd. 255
Not applicableLooking for participantsNCT07158463
What this trial is testing

Experience With Therapeutic Plasma Exchange in the Pediatric Nephrology Unit of Sohag University Hospital

Who this might be right for
Experience With Therapeutic Plasma Exchange in the Pediatric Nephrology Unit
Sohag University 25
Not applicableNot Yet RecruitingNCT07376512
What this trial is testing

Predicting Response to Anti-PD-1/PD-L1 Immunotherapy by Plasma Extracellular Vesicle Analysis

Who this might be right for
Non-Small Cell Lung CancerMelanoma (Skin Cancer)
Centre Georges Francois Leclerc 378
Large-scale testing (Phase 3)UnknownNCT02362165
What this trial is testing

CyBorD vs. PAD in the Treatment of Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sun Yat-sen University 236
Testing effectiveness (Phase 2)Looking for participantsNCT05099471
What this trial is testing

Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia

Who this might be right for
Waldenstrom MacroglobulinemiaTreatment Naive
Christian Buske 80
Large-scale testing (Phase 3)UnknownNCT02575144
What this trial is testing

GEM-CLARIDEX: Ld vs BiRd

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 286
Large-scale testing (Phase 3)UnknownNCT04873414
What this trial is testing

Convalescent Plasma as Adjunct Therapy for COVID-19

Who this might be right for
COVID-19
National Institute of Health Research and Development, Ministry of Health Republic of Indonesia 364
Not applicableLooking for participantsNCT06784167
What this trial is testing

Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment

Who this might be right for
Chronic Lymphocytic LeukemiaDiffuse Large B-Cell LymphomaFollicular Lymphoma+4 more
OHSU Knight Cancer Institute 45
Not applicableLooking for participantsNCT07558564
What this trial is testing

Evaluation of Platelet-Rich Plasma (PRP) Treatment in Tendinopathies

Who this might be right for
Patellar TendinopathyAchilles Tendinopathy (AT)Epicondylitis, Lateral+1 more
ReSport Clinic 2,000
Not applicableLooking for participantsNCT06543316
What this trial is testing

Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment

Who this might be right for
Roux-en-y Anastomosis SiteMarginal UlcerMarginal Ulcer (Peptic) or Erosion+9 more
Christopher C. Thompson, MD, MSc 100
Testing effectiveness (Phase 2)Study completedNCT01577095
What this trial is testing

Evaluating the Effects of Electroacupuncture and Rosiglitazone Combined Therapy

Who this might be right for
Type 2 Diabetes Mellitus With Features of Insulin Resistance
China Medical University Hospital 49
Testing effectiveness (Phase 2)Ended earlyNCT04352205
What this trial is testing

Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure

Who this might be right for
Plasma Cell MyelomaRenal Failure
Emory University 17
Testing effectiveness (Phase 2)Looking for participantsNCT07081646
What this trial is testing

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

Who this might be right for
Relapsed AL AmyloidosisRefractory AL AmyloidosisLight Chain Amyloidosis+1 more
Alexion Pharmaceuticals, Inc. 91
Not applicableStudy completedNCT04033029
What this trial is testing

Antibiotic Plasma Concentrations During Continuous Renal Replacement Therapy With a High Adsorption Membrane (oXiris®)

Who this might be right for
HemodiafiltrationSepsisAcute Kidney Injury
Hospital Universitari de Bellvitge 20
Post-approval studies (Phase 4)Study completedNCT00151853
What this trial is testing

Study Use of PPSB-SD and VP-VI in Patients With Anticoagulant Therapy and Undergoing Acute CPB Surgery

Who this might be right for
CPBOral Anticoagulant Therapy
Prothya Biosolutions 40
Next Page